Ignite Creation Date:
2024-05-06 @ 3:19 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04597905
Status:
COMPLETED
Last Update Posted:
2021-02-11
First Post:
2020-10-19
Brief Title:
Paricipant Preferences in the Treatment of Inflammatory Bowel Disease IBD in Europe
Sponsor:
Takeda
Organization:
Takeda
Study Overview
Official Title:
Observational Study to Define Patient Preferences Toward the Attributes of Treatment Used for Inflammatory Bowel Disease Including Efficacy Profile Safety Profile Frequency and Route of Administration in Europe
Status:
COMPLETED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this survey is to describe Crohns disease CD participants as well as ulcerative colitis UC participants preferences towards the attributes of treatment with advanced therapies for IBD including safety and efficacy profiles frequency and route of administration RoA in a real-world setting
Detailed Description:
This is a descriptive observational cross-sectional survey of participants with IBD The survey will look into the preferences of participants towards the attributes of treatment with advanced therapies for IBD based on DCE experimentally designed survey including safety and efficacy profiles frequency and RoA in a real-world setting in European participants living with CD or UC
The survey will involve data collection in a real-world setting via an online self-reported questionnaire hosted on the Carenity platform an international participant community
The survey will enroll approximately 600 participants Participants will be enrolled in two observational cohorts
CD Participants
UC Participants
This multi-center trial will be conducted in France the United Kingdom Italy Spain Belgium Switzerland the Netherlands
The survey will involve data collection in a real-world setting via an online self-reported questionnaire hosted on the Carenity platform an international participant community
The survey will enroll approximately 600 participants Participants will be enrolled in two observational cohorts
CD Participants
UC Participants
This multi-center trial will be conducted in France the United Kingdom Italy Spain Belgium Switzerland the Netherlands
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U1111-1259-3241 | REGISTRY | WHO | None |